COVID-19 and the Drug Repurposing Tsunami
Author:
Affiliation:
1. H.M. Pharma Consultancy, Vienna, Austria.
Publisher
Mary Ann Liebert Inc
Subject
Drug Discovery,Molecular Medicine
Link
https://www.liebertpub.com/doi/pdf/10.1089/adt.2020.996
Reference17 articles.
1. Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24–April 21, 2020
2. The first two cases of 2019‐nCoV in Italy: Where they come from?
3. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020
4. A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Computational insight of repurpose drug for treatment of COVID-19: a CDFT approach;Theoretical Chemistry Accounts;2023-12-27
2. OntoloViz: a GUI for interactive visualization of ranked disease or drug lists using the MeSH and ATC ontologies;Bioinformatics Advances;2023-08-23
3. A Multi-dimensional Review on Severe Acute Respiratory Syndrome Coronavirus-2;Current Pharmaceutical Biotechnology;2023-07
4. Exploration of Repurposed and Adjuvant Drugs in COVID-19 Patients, as well as Challenges and Ethical Issues Related to Drug Repurposing;Drug Repurposing Against SARS-CoV-2;2023-04-12
5. Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001;International Medical Case Reports Journal;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3